A new presidential memorandum requires the Department of Health and Human Services to coordinate a government-wide push to generate a research action plan for the condition.
After lobbying efforts from lawmakers and science advisors, the new, DARPA-like biomedical research agency will be a part of the National Institutes of Health, but its director will report directly to the secretary of Health and Human Services.
The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.
The University of Washington researcher leveraged data from the Human Genome Project to identify genes underlying various health conditions and advance precision medicine.
The glycoprotein researcher and longtime principal deputy director of the National Institutes of Health will take over from Francis Collins on December 20.
Current evidence suggests the treatment does not improve survival or reduce the need for ventilation in COVID-19 patients, the World Health Organization says.
In his book’s Introduction, physician-scientist Paul A. Offit reviews the unusual constellation of circumstances around the development of COVID-19 vaccines.
The revision allows more time on previous extensions due to COVID-19 and other life events such as childbirth that disproportionately impact early-career women in science.
The NIH shared new data detailing complaints it has received in recent years, the latest in a series of steps taken by funding agencies and professional organizations to address misconduct.
A new ruling removes the requirement that grants and proposals using the material receive approval from an ethical review board, reverting to the process in place before 2019.
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.